tiprankstipranks
Trending News
More News >
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
US Market

Arcadia Biosciences (RKDA) Financial Statements

Compare
479 Followers

Arcadia Biosciences Financial Overview

Arcadia Biosciences's market cap is currently $3.30M. The company's EPS TTM is $-0.848; its P/E ratio is -0.65; Arcadia Biosciences is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 5.04M$ 4.45M$ 7.42M$ 6.78M$ 8.03M
Gross Profit$ 2.08M$ 2.28M$ 1.32M$ -1.93M$ 2.83M
Operating Income$ -3.65M$ -6.10M$ -14.01M$ -35.53M$ -12.78M
EBITDA$ -7.50M$ -5.73M$ -14.75M$ -27.71M$ -5.44M
Net Income$ -7.04M$ -13.98M$ -15.38M$ -14.66M$ -4.66M
Balance Sheet
Cash & Short-Term Investments$ 4.24M$ 11.64M$ 20.64M$ 28.68M$ 25.67M
Total Assets$ 13.52M$ 19.70M$ 28.92M$ 43.92M$ 47.35M
Total Debt$ 155.00K$ 1.01M$ 2.02M$ 3.29M$ 9.35M
Net Debt$ -4.09M$ -5.51M$ -18.63M$ -25.39M$ -4.69M
Total Liabilities$ 7.29M$ 7.00M$ 8.02M$ 12.72M$ 18.80M
Stockholders' Equity$ 6.22M$ 12.84M$ 21.03M$ 31.09M$ 27.73M
Cash Flow
Free Cash Flow$ -9.64M$ -15.30M$ -14.05M$ -26.88M$ -32.55M
Operating Cash Flow$ -9.63M$ -15.29M$ -13.98M$ -25.87M$ -30.22M
Investing Cash Flow$ 7.34M$ -4.34M$ 1.42M$ 16.61M$ 17.28M
Financing Cash Flow$ 9.00K$ 5.51M$ 4.52M$ 21.90M$ 20.56M
Currency in USD

Arcadia Biosciences Earnings and Revenue History

Arcadia Biosciences Debt to Assets

Arcadia Biosciences Cash Flow

Arcadia Biosciences Forecast EPS vs Actual EPS